Literature DB >> 17451171

Magnetic resonance imaging and spectroscopy of transgenic models of cancer.

Venu Raman1, Arvind P Pathak, Kristine Glunde, Dmitri Artemov, Zaver M Bhujwalla.   

Abstract

The complexity of cancer, where a single genetic alteration can have multiple functional effects, makes it a fascinating but humbling disease to study, and the necessity of investigating it in its entirety is more imperative than ever before. Advances in transgene technology have made it possible to create cancer cells, or mice with specific genetic alterations, and the application of an array of both functional and molecular non-invasive MR methods to these transgenic cancer cells and mice to characterize their phenotypic traits is revolutionizing our understanding of cancer. With the establishment of multi-modality molecular imaging centers within barrier or pathogen-free facilities, multi-parametric and multi-modality imaging of transgenic mouse models of human cancer are becoming increasingly prevalent. In this review, we outline some of the methods currently available for generating transgenic mice and cancer cell lines. We also present examples of the application of MR methods to transgenic models that are providing novel insights into the molecular and functional characteristics of cancer and are leading to an era of "non-invasive phenotyping" of the effects of specific molecular alterations in cancer. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17451171     DOI: 10.1002/nbm.1136

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  7 in total

Review 1.  Molecular and functional MRI of the tumor microenvironment.

Authors:  Marie-France Penet; Kristine Glunde; Michael A Jacobs; Arvind P Pathak; Zaver M Bhujwalla
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057

2.  In Vivo Imaging With Confirmation by Histopathology for Increased Rigor and Reproducibility in Translational Research: A Review of Examples, Options, and Resources.

Authors:  Kathleen Gabrielson; Robert Maronpot; Sébastien Monette; Coraline Mlynarczyk; Yuval Ramot; Abraham Nyska; Polina Sysa-Shah
Journal:  ILAR J       Date:  2018-12-01

3.  Vascular phenotyping of brain tumors using magnetic resonance microscopy (μMRI).

Authors:  Eugene Kim; Jiangyang Zhang; Karen Hong; Nicole E Benoit; Arvind P Pathak
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-09       Impact factor: 6.200

4.  Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.

Authors:  Ho-Taek Song; Elaine K Jordan; Bobbi K Lewis; Wei Liu; Justin Ganjei; Brenda Klaunberg; Daryl Despres; Diane Palmieri; Joseph A Frank
Journal:  J Transl Med       Date:  2009-10-20       Impact factor: 5.531

5.  Comparison of tetraploid blastocyst microinjection of outbred Crl:CD1(ICR), hybrid B6D2F1/Tac, and inbred C57BL/6NTac embryos for generation of mice derived from embryonic stem cells.

Authors:  Sharron M Kirchain; Alison M Hayward; John M Mkandawire; Peimin Qi; Aurora A Burds
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

6.  Tumour size measurement in a mouse model using high resolution MRI.

Authors:  Mikael Montelius; Maria Ljungberg; Michael Horn; Eva Forssell-Aronsson
Journal:  BMC Med Imaging       Date:  2012-05-30       Impact factor: 1.930

7.  Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma.

Authors:  Rebecca L Allchin; Michael E Kelly; Sami Mamand; Anthony G Doran; Thomas Keane; Matthew J Ahearne; Simon D Wagner
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.